Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nelfinavir and Lenalidomide/Dexamethasone in Patients With Progressive Multiple Myeloma That Have Failed Lenalidomide-containing Therapy - A Single Arm Phase I/II Trial

NCT01555281 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT01555281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01555281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nelfinavir and Lenalidomide/Dexamethasone in Patients With Progressive Multiple Myeloma That Have Failed Lenalidomide-containing Therapy - A Single Arm Phase I/II Trial
Lead sponsor
Swiss Cancer Institute
Phase
Phase 1/2
Overall status
Terminated
Start date
February 23, 2012
Completion date
June 8, 2022
Enrollment
33 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma